Senior Scientist, Jim Eckstein Presents
Poster on the Analytical Challenges involved
with the Evolving Structures of Therapeutic Peptides
Recently, AIT Bioscience attended the 13th Annual Boulder Peptide Symposium in Boulder, Colorado. During this year’s event, we shared our recent expertise in peptide research and collaborated with other leaders in the bioanalytical industry. Topics featured technological advances in Diabetes, Alzheimer’s Disease, immunotherapy, peptide antibiotics, peptide delivery and oral availability of peptides.
During the event, Senior Scientist, Jim Eckstein, presented a poster titled “The Evolution of Therapeutic Peptide Structures as it Relates to Analytical Challenges.” Jim’s presentation explored how analytical strategies for peptide analysis have had to adjust to keep up with the structural advances in therapeutic peptides which have provided improved ADME characteristics to these molecules. With the recent addition of our high-resolution mass spectrometry (HRMS) capabilities, AIT Bioscience is able to analyze a wide variety of peptide motifs more efficiently to deliver better results for our sponsors.
AIT Bioscience streamlines therapeutic peptide development by our collaborative collocation of small and large molecule expertise within one facility. Learn more about our peptide capabilities and contact us for more information about the insights we gained from this event. Also, read our recent blog post to learn about our Thermo Q-Exactive Plus® platform for HRMS services.